​​Saeed A. Jortani Ph.D., DABCC

Contact Us:










Dr. Jortani is a Professor of Pathology and Laboratory Medicine at the University of Louisville School of Medicine.  He is a board-certified clinical chemist and a practicing toxicologist.  He is the Chief of University of Louisville’s Clinical Chemistry and Toxicology Laboratory and the Director of Clinical Chemistry and Toxicology at Jewish Hospital.  He has served as a representative of several national organizations in the area of laboratory medicine such as the American Association for Clinical Chemistry (AACC), American Board for Clinical Chemistry (ABCC) and the Commission on Accreditation in Clinical Chemistry (ComACC). 


Dr. Jortani is a co-founder of the Mass Spectrometry and Separation Sciences Division of the AACC.  He is on the editorial boards of ClinicaChemica Acta and Clinical Proteomics, Therapeutic Drug Monitoring.  His research interests are proteomics, detection and measurement of drugs, therapeutics and poisons, and the use of pharmacogenetics in pain management and for postmortem investigations. As the founder of KCTL, Dr. Jortani has served the diagnostic industry for over 20 years.  He has secured several million dollars of funding for clinical research.  He has been a co-inventor on several patent applications, all of which are various stages of discovery proceeding toward translation and novel diagnostics.


Dr. Jortani is also one of the leaders in the field of pharmacogenetics specifically focusing on personalized pain management and PGx-guided forensic toxicology investigations and pain management.  As a liaison representing the AACC to the College of American Pathologists, he co-founded the first proficiency testing materials in the area of clinical pharmacogenetics.  His efforts by participating in the writing of the Laboratory Medicine Practice Guidelines in Pharmacogenetics and his directing of clinical trials in this area will contribute to substantial advancement in this area.


With over 30 years of Clinical Trials experience,  Dr Jortani is committed to ensure your sponsored research be conducted in a rapid and yet exemplary manner.   


Additional Websites associated with Dr. Jortani:
University of Louisville School of Medicine, Department of Pathology & Laboratory






 Publication Examples

Verification of Newly FDA-Approved Kappa and Lambda Free Light Chain Assays on a Previously Untested Platform

A. Jortani, Saeed & Pozzi, Nicole & N. Sharp, Cierra & Muluhngwi, Penn & J. Elin, Ronald 

May 2019 






Long interspersed nuclear element-1 mobilization as a target in cancer diagnostics, prognostics, and therapeutics 

Lavasanifar, Afsaneh & N. Sharp, Cierra & Korte, Erik & Yin, Tyler & Hossainijad, Keivan & A. Jortani, Saeed.

Feb 2019





Discovery of the Long Interspersed Nuclear Element-1 activation product [Open Reading Frame-1 (ORF1) protein] in human blood

Hossainijad, Keivan & Yin, Tyler & T. Gaskins, Jeremy & L. Bailan, James & A. Jortani, Saeed. 

Oct 2018





Lack of Influence by CYP3A4 and CYP3A5 Genotypes on Pain Relief by Hydrocodone in Postoperative Cesarean Section Pain Management 

Hossainijad, Keivan & Yin, Tyler, & T. Gaskins, Jeremy, & Elaine Stauble, M & Wu, Yanhong & Jannetto, Paul & L. Langman, Loralie & A. Jortani, Saeed.

Sep 2018





Analytical interference of HBOC-201 (Homopure, a synthetic hemoglobin-based oxygen carrier) on four common clinical chemistry platforms 

Korte, Erik & Pozzi, Nicole & Wardrip, Nina & Tayyeb Ayyoubi, M & A. Jortani, Saeed. 

July 2018






Multicenter evaluation of analytical characteristics of the Elecsys Periostin immunoassay 

Palme, Stefan & H. Christenson, Robert A. Jortani, Saeed & E. Ostlund, Richard & Kolm, Ruediger & Kopal, Guido & P. Laubender, Ruediger. 

Feb 2017